Skip to content


  • Short report
  • Open Access

Human herpesvirus 6 infection impairs Toll-like receptor signaling

  • 1,
  • 1,
  • 1, 2,
  • 1,
  • 1,
  • 1,
  • 1, 2 and
  • 1, 2Email author
Virology Journal20107:91

  • Received: 11 March 2010
  • Accepted: 10 May 2010
  • Published:


Human herpesvirus 6 (HHV-6) has a tropism for immunocompetent cells, including T lymphocytes, monocytes/macrophages, and dendritic cells (DCs) suggesting that HHV-6 infection affects the immunosurveillance system. Toll-like receptor (TLR) system plays an important role in innate immunity against various pathogens. In the present study, we investigated the effect of HHV-6 infection on the expression and intracellular signaling of TLRs in DCs. Although expression levels of TLRs were not decreased or slightly elevated following HHV-6 infection, the amounts of cytokines produced following stimulation with ligands for TLRs appeared to be dramatically decreased in HHV-6-infected DCs as compared to mock-infected DCs. Similarly, phosphorylation levels of TAK-1, IκB kinase, and IκB-α following stimulation of HHV-6-infected DCs with lipopolysaccharide, which is the ligand for TLR4, appeared to be decreased. These data show that HHV-6 impairs intracellular signaling through TLRs indicating the novel mechanism of HHV-6-mediated immunomodulation.


  • TLR4 Expression
  • Adaptor Molecule
  • Bystander Effect
  • Vaccinia Virus Infection
  • Imidazoquinoline


Human herpesvirus 6 (HHV-6) is known as a causative agent of exanthem subitum, and reactivation of HHV-6 in adults causes various clinical manifestations [1, 2]. HHV-6 can preferentially infect immunocompetent cells and induces various immunobiological alterations [312]. Therefore, HHV-6 is recognized as one of the important viruses that modulate immune responses.

Toll-like receptors (TLRs) are key molecules of the innate immune system [13]. A subset of TLRs recognizes components of microorganisms and induces innate immune responses. After recognition of ligands, TLRs activate their intrinsic signaling pathways, resulting in activation of the transcription factor nuclear factor-κB (NF-κB), which controls the expression of inflammatory cytokine genes [14, 15]. HHV-6 alters the regulation of innate immunity as well as adaptive immunity. In the light of these facts, it seems important to clarify the effects of HHV-6 infection on the TLR system. We therefore investigated the effects of HHV-6 infection on the expression and functions of TLRs in DCs.

The Z29 strain of HHV-6B was mainly used in the present study, because HHV-6B is more prevalent than HHV-6A in the general population. Immature DCs were generated from peripheral blood monocytes by culturing them in the presence of GM-CSF and IL-4, as described previously [8]. Immature DCs were inoculated with HHV-6 at an approximate multiplicity of infection of 1 50% tissue culture infective dose. HHV-6-inoculated DCs were cultured for 3 days and used for experiments. More than 95% of HHV-6-infected and mock-infected DCs were viable when used for experiments.

Expression of mRNA for TLRs1-10 in HHV-6-infected and mock-infected DCs was examined by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) [16]. Sequences of the primers for PCR are shown in the additional file 1.

Cytokine production by DCs was examined as follows. After 3 days of HHV6 inoculation, DCs were cultured for 24 hours in RPMI 1640 medium supplemented with 10% fetal calf serum and poly(I:C) (a ligand for TLR 3; Invitrogen, San Diego, CA, USA) at 25 μg/ml, lipopolysaccharide (LPS) (a ligand for TLR 4; Sigma, St Louis, MO, USA) at 100 ng/ml, or imidazoquinoline (a ligand for TLR7; Invitrogen) at 5 mg/ml. The culture supernatants were then harvested, and the amounts of cytokines they contained were measured by flow cytometry using a Cytometric Bead Array System (BD Biosciences, San Diego, CA, USA) and enzyme-linked immunosorbent assay (Biosource Europe S.A., Nivelles, Belgium).

The binding of LPS to HHV-6-infected and mock-infected DCs was examined quantitatively by flow cytometry using fluorescent LPS conjugate (Alexa Fluor® 488) (Molecular Probes, Eugene, OR, USA).

Western blotting was performed by a standard method using the following antibodies; anti-TLR4 (BioChain, Hayward, CA, USA), anti-MyD88 (ProSci, Poway, CA, USA), anti-TRAF6 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-TAK-1 (Cell Signaling Technology, Danvers, MA, USA), anti-phosphorylated IκB kinase α/β (IKKα/β) (Cell Signaling Technology), anti-phosphorylated IκB-α (Cell Signaling Technology), and anti-β-actin (Sigma).

We first confirmed HHV-6 infection in DCs. We and other investigators previously reported that HHV-6 can infect human DCs and modulates the expression of various surface molecules including CD80, CD83, CD86, and DC-SIGN [8, 9, 17]. As shown in the additional file 2, expression of HHV-6 immediate early and late genes was detected in HHV-6-inoculated DCs. In addition, two-color flow cytometry showed that HHV-6 antigen expression was present in more than half of the DCs inoculated with HHV-6. HHV-6 antigen expression was detected in DCs in which CD80 expression was up-regulated, as we have reported previously [8] (Additional file 3). These data confirmed that HHV-6 was able to infect DCs under our experimental conditions.

We screened the TLR1-10 expression in HHV-6-infected DCs and compared it with that in mock-infected DCs. As shown in Figure 1, semi-quantitative RT-PCR revealed that expression of mRNAs for TLR3, TLR4, and TLR7 appeared to be slightly increased in HHV-6-infected DCs as compared with mock-infected DCs.
Figure 1
Figure 1

RT-PCR analysis of TLR mRNAs in mock-infected and HHV-6-infected DCs. Semi-quantitative RT-PCR reveals that expression levels of mRNAs for TLR3, TLR4, and TLR7 are slightly higher in HHV-6-infected DCs than in mock-infected DCs.

We next examined cytokine production by HHV-6-infected and mock-infected DCs in response to stimulation with TLR ligands. TLR3, TLR4, and TLR7 were selected for this experiment, because expression of these TLRs seemed to be increased after infection with HHV-6, as shown in Figure 1. As shown in Figure 2, the amounts of IL-6 and IL-8 produced by DCs stimulated with poly(I:C), a TLR3 ligand, after infection with HHV-6 appeared to be significantly lower than those produced by mock-infected DCs. Similarly, the production of IL-10 and IL-8 by HHV-6-infected DCs in response to stimulation with LPS, a TLR4 ligand, was markedly impaired in comparison with mock-infected DCs. The amount of IL-8 produced by HHV-6-infected DCs stimulated with a TLR7 ligand, imidazoquinoline, was also decreased as compared with that produced by TLR7 ligand-stimulated mock-infected DCs. The same experiments were performed three times and similar data were obtained.
Figure 2
Figure 2

Downregulation of cytokine production by stimulation with TLR ligand in DCs after infection with HHV-6. The production of cytokines by HHV-6-infetced DCs and mock-infected DCs was examined as detailed in the text. The amounts of cytokines produced by HHV-6-infected DCs after stimulation with the TLR3 ligand poly(I:C), the TLR4 ligand LPS, and the TLR7 ligand imidazoquinoline are all lower than those produced by mock-infected DCs that were stimulated with TLR ligands.

We further examined the mechanisms of impaired cytokine production by HHV-6-infected DCs, focusing on TLR4. First, expression of the TLR4 molecule on HHV-6-infected and mock-infected DCs was examined by Western blotting of cell lysates and flow cytometry to detect the binding of fluorescent LPS conjugate. As shown in Figures 3A and 3B, the level of TLR4 expression on HHV-6-infected DCs unstimulated with LPS appeared to be slightly higher than that on mock-infected DCs.

The intracellular signaling system of TLR4 in HHV-6-infected and mock-infected DCs was further examined. First, it appeared that the amount of MyD88, an adaptor molecule required for signal transduction through TLRs, was slightly higher in HHV-6-infected DCs than in mock-infected DCs, parallel to the TLR4 expression level. Similarly, the expression level of TRAF6, another TLR adaptor molecule, did not differ significantly, or was slightly increased, in HHV-6-infected as compared with mock-infected DCs (Figure 3C). In contrast, phosphorylation levels of TAK-1, IKKα/β, and IκB-α, which are important molecules for NF-κB activation [18], in HHV-6-infected DCs after stimulation with LPS appeared to be significantly lower than those in LPS-stimulated mock-infected DCs (Figure 3D). The same experiments were performed twice and similar data were obtained. These data reveal that HHV-6 impairs signal transduction of TLRs.
Figure 3
Figure 3

Impairment of TLR4 signaling in HHV-6-infected DCs. (A) Western blotting reveals that the expression level of TLR4 protein in HHV-6-infected DCs, which were not stimulated with LPS, is slightly higher than that in mock-infected DCs. (B) Flow cytometric analysis using fluorescent LPS conjugate reveals that the amount of LPS bound to HHV-6-infected DCs is slightly higher than that on mock-infected DCs, suggesting that the expression level of TLR4 molecules on DCs is increased after infection with HHV-6. (C) Western blotting reveals that the expression levels of MyD88 and TRAF6 proteins in HHV-6-infected DCs, which are not stimulated with LPS, are slightly higher than those in mock-infected DCs. (D) Western blotting reveals that phosphorylation levels of TAK-1, IKKα/β and IκB-α in HHV-6-infected DCs after stimulation with LPS are significantly lower than those in LPS-stimulated mock-infected DCs.

In the present study, we demonstrated that although the expression of TLRs and their adaptor molecules was only slightly increased, cytokine production by DCs in response to stimulation with TLR ligands was severely impaired after infection with HHV-6. In contrast, phosphorylation levels of TAK-1, IKKα/β and IκB-α appeared to be significantly decreased in HHV-6-infected DCs as compared with mock-infected DCs. NF-κB activation resulting in production of inflammatory cytokines depends on phosphrylation of IκB, which is induced by activation of the IKK complex [18, 19]. Activation of IKKs depends on their phosphorylation, which results in conformational change and kinase activity [2022]. It is also noteworthy that impaired cytokine production is not restricted in the TLR4 system but is also detected in the signal pathways of other TLRs. Therefore, these findings suggest that impairment of TLR4 signaling in HHV-6-infected DCs is due to blocking not upstream, but downstream in the signal pathway.

Recently, various effects of viral infection on expression and signaling of TLRs have been reported. Chen et al. have recently reported that vaccinia virus virulence factor B14 can directly bind to the IKK complex and inhibit phosphorylation of IKKβ[23]. This results in impairment of IκB-α degradation and inhibition of NF-κB activation. In the present study, it was found that inoculation with inactivated HHV-6 did not induce impairment of TLR signaling, i.e., the amounts of cytokines produced by HHV-6-infected and inactivated HHV-6-inoculated DCs following stimulation with TLR ligands were not significantly different (data not shown). Therefore, HHV-6 gene product(s) produced de novo in HHV-6-infected DCs might associate with the TAK-1 or IKK complex directly or indirectly, resulting in inhibition of IKK activation, as is the case for vaccinia virus infection. It has also been reported that M45 protein of murine cytomegalovirus, which, like HHV-6, is a β-herpesvirus, inhibits the RIP1-mediated activation of NF-κB in response to TLR3 stimulation [24]. This finding suggests that impairment of TLR signaling might be the common strategy of immune evasion by β-herpesviruses.

Viruses alter cell functions via mainly direct infection; however, indirect mechanisms are also responsible for virus-mediated immune-modulation. We previously reported that HHV-6 infection mediates apoptosis in HHV-6-uninfected T cells through a bystander effect [25]. In the present study, it was not clarified whether a direct or a bystander effect plays an important role in impairment of the innate immune response in HHV-6 infection. Further study will be needed to clarify this issue.

In summary, we have demonstrated for the first time that the intracellular signaling pathway through TLRs is severely impaired by HHV-6 infection. Since the TLR system is essential for recognition of various pathogens and generation of innate immunity, disruption of TLR-mediated signaling seems to be an effective strategy by which viruses can evade the immunosurveillance system.



We are grateful for the skilled technical assistance of Ms. Junko Mizumoto and Dr. Kenji Kameda, Ehime University, Japan. We also thank Dr. Yasuko Mori, Kobe University Graduate School of Medicine for kindly supplying anti-HHV-6 antibody. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Authors’ Affiliations

Departmemt of Bioregulatory Medicine, Ehime University Graduate School of Medicine, 791-0295, Japan
Proteo-Medicine Research Center, Ehime University, 791-0295, Japan


  1. De Bolle L, Naesens L, De Clercq E: Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 2005, 18: 217-245. 10.1128/CMR.18.1.217-245.2005PubMedPubMed CentralView ArticleGoogle Scholar
  2. Zerr DM: Human herpesvirus 6: a clinical update. Herpes 2006, 13: 20-24.PubMedGoogle Scholar
  3. Furukawa M, Yasukawa M, Yakushijin Y, Fujita S: Distinct effects of human herpesvirus 6 and human herpesvirus 7 on surface molecule expression and function of CD4 + T cells. J Immunol 1994, 152: 5768-5775.PubMedGoogle Scholar
  4. Hasegawa A, Yasukawa M, Sakai I, Fujita S: Transcriptional down-regulation of CXCR4 induced by impaired association of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells. J Immunol 2001, 166: 1125-1131.PubMedView ArticleGoogle Scholar
  5. Lusso P, De Maria A, Malnati M, Lori F, DeRocco SE, M Baseler M, Gallo RC: Induction of CD4 and susceptibility to HIV-1 infection in human CD8 + T lymphocytes by human herpesvirus 6. Nature 1991, 349: 533-535. 10.1038/349533a0PubMedView ArticleGoogle Scholar
  6. Lusso P, Malnati M, De Maria A, Balotta C, DeRocco SE, Markham PD, Gallo RC: Productive infection of CD4 + and CD8 + mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J Immunol 1991, 147: 685-691.PubMedGoogle Scholar
  7. Lusso P, Malnati MS, Garzino-Demo A, Crowley RW, Long EO, Gallo RC: Infection of natural killer cells by human herpesvirus 6. Nature 1993, 362: 458-462. 10.1038/362458a0PubMedView ArticleGoogle Scholar
  8. Kakimoto M, Hasegawa A, Fujita S, Yasukawa M: Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection. J Virol 2002, 76: 10338-10345. 10.1128/JVI.76.20.10338-10345.2002PubMedPubMed CentralView ArticleGoogle Scholar
  9. Niiya H, Azuma T, Jin L, Uchida N, Inoue A, Hasegawa H, Fujita S, Tohyama M, Hashimoto K, Yasukawa M: Transcriptional downregulation of DC-SIGN in human herpesvirus 6-infected dendritic cells. J Gen Virol 2004, 85: 2639-2642. 10.1099/vir.0.80095-0PubMedView ArticleGoogle Scholar
  10. Niiya H, Lei J, Guo Y, Azuma T, Yakushijin Y, Sakai I, Hato T, Tohyama M, Hashimoto K, Yasukawa M: Human herpesvirus 6 impairs differentiation of monocytes to dendritic cells. Exp Hematol 2006, 34: 642-653. 10.1016/j.exphem.2006.02.001PubMedView ArticleGoogle Scholar
  11. Smith A, Santoro F, Di Lullo G, Dagna L, Verani A, Lusso P: Selective suppression of IL-12 production by human herpesvirus 6. Blood 2003, 102: 2877-2884. 10.1182/blood-2002-10-3152PubMedView ArticleGoogle Scholar
  12. Yasukawa M, Hasegawa A, Sakai I, Ohminami H, Arai J, Kaneko S, Yakushijin Y, Maeyama K, Nakashima H, Arakaki R, Fujita S: Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7. J Immunol 1999, 162: 5417-5422.PubMedGoogle Scholar
  13. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003, 21: 335-376. 10.1146/annurev.immunol.21.120601.141126PubMedView ArticleGoogle Scholar
  14. Kawai T, Akira S: Signaling to NF-κB by Toll-like receptors. Trends Mol Med 2007, 13: 460-469. 10.1016/j.molmed.2007.09.002PubMedView ArticleGoogle Scholar
  15. Trinchieri G, Sher A: Cooperation of Toll-like receptor signals in innate immune defense. Nat Rev Immunol 2007, 7: 179-190. 10.1038/nri2038PubMedView ArticleGoogle Scholar
  16. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001, 194: 863-869. 10.1084/jem.194.6.863PubMedPubMed CentralView ArticleGoogle Scholar
  17. Takemoto M, Imasawa T, Yamanishi K, Mori Y: Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4 + T cells. Virology 2009, 385: 294-302. 10.1016/j.virol.2008.11.049PubMedView ArticleGoogle Scholar
  18. Baeuerle PA, Baltimore D: I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988, 242: 540-546. 10.1126/science.3140380PubMedView ArticleGoogle Scholar
  19. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M: The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 1997, 91: 243-252. 10.1016/S0092-8674(00)80406-7PubMedView ArticleGoogle Scholar
  20. Delhase M, Hayakawa M, Chen Y, Karin M: Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation. Science 1999, 284: 309-313. 10.1126/science.284.5412.309PubMedView ArticleGoogle Scholar
  21. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M: A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 1997, 388: 548-554. 10.1038/41493PubMedView ArticleGoogle Scholar
  22. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A: IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 1997, 278: 860-866. 10.1126/science.278.5339.860PubMedView ArticleGoogle Scholar
  23. Chen RA, Ryzhakov G, Cooray S, Randow F, Smith GL: Inhibition of IκB kinase by vaccinia virus virulence factor B14. PLos Pathog 2008, 4: e22. 10.1371/journal.ppat.0040022PubMedPubMed CentralView ArticleGoogle Scholar
  24. Mack C, Sickmann A, Lembo D, Brune W: Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc Natl Acad Sci USA 2008, 105: 3094-3099. 10.1073/pnas.0800168105PubMedPubMed CentralView ArticleGoogle Scholar
  25. Inoue Y, Yasukawa M, Fujita S: Induction of T-cell apoptosis by human herpesvirus 6. J Virol 1997, 71: 3751-3759.PubMedPubMed CentralGoogle Scholar


© Murakami et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.